Oncolytics Biotech’s (ONCY) “Buy” Rating Reaffirmed at HC Wainwright
Oncolytics Biotech (NASDAQ:ONCY – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research report issued on Wednesday,Benzinga reports. They currently have a $5.00 price target on the stock. Other research analysts have also recently issued research reports about the company. Royal Bank of Canada dropped their […]
Oncolytics Biotech (NASDAQ:ONCY – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research report issued on Wednesday,Benzinga reports. They currently have a $5.00 price target on the stock. Other research analysts have also recently issued research reports about the company. Royal Bank of Canada dropped their […]
